WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: APRIL ISSUE PUBLISHED
  • April Issue has been successfully launched on 1 April 2024.

Abstract

A STUDY ON THE EFFECT OF MILTEFOSINE DRUG ON NOTCH PATHWAY INDUCING APOPTOSIS IN HUMAN BREAST CANCER CELLS

Ranjana Singh*, Vivek Singh, Nimra Habib and Abbas Ali Mahdi

ABSTRACT

Breast cancer is one of the leading causes of cancer death in women, for this problem we still needs a new kind of drugs for the treatment, here in this study we had repurposed the miltefosine for the treatment of breast cancer. While on molecular domain Notch proteins play crucial roles in shaping cell fates such as proliferation, differentiation and apoptosis. Role of Notch signaling in human breast cancer has been suggested by the development of adenocarcinomas in the murine mammary gland. However, it is not clear whether Notch signaling is frequently expressed and activated in breast cancers. From this study we had found that Notch signaling was over expressed and highly activated in breast cancer cell lines, on other side we had checked efficacy of miltefosine as anticancer molecule on (MCF-7, MDA-MB-231) breast cancer cell lines that leads to apoptosis. However the genomic & proteomics observations also indicated that miltefosine can downregulate the Akt, Notch (1, 2, 3, & 4) and thus, opening a new gateway to combat multi drug resistant conditions in breast cancer.

Keywords: Notch, Breast Cancer, Akt, Miltefosine.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More